📰 Amyloidosis Program News
Amyloidosis Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amyloidosis Program. Real-time updates on events, politics, business and more.
May 29, 2024
Early Increase in Serum Transthyretin Level Is an Independent Predictor of Improved Survival in ATTR Cardiomyopathy: Insights From Acoramidis Phase 3 Study ATTRibute-CM ...
September 1, 2023
Dr. Lentzsch joins the Nexcella Scientific Advisory Board with decades of experience treating patients with AL Amyloidosis and multiple myeloma and serving as a principal investigator on clinical...
August 18, 2023
Dr. Landau joins the Nexcella Scientific Advisory Board with decades of hematology/oncology clinical trial experience at Memorial Sloan Kettering Cancer Center Dr. Landau is a recognized thought...
July 29, 2023
A new multi-center study led by doctors at Boston Medical Center and Columbia University found that having a genetic variant in the prealbumin gene alone is not sufficient for diagnosis of transthyretin amyloid cardiomyopathy in older Black patients.
May 16, 2023
The most common form of heart failure in older adults can be challenging to manage. An update at AGS addressed diagnosis, medications, inequities, and the role of exercise.
August 24, 2022
Numbness and tingling in her feet, heart palpitations, dizzy spells and wrist pain that felt like carpal tunnel syndrome pushed Nancy Kim to confirm that she has the same rare genetic condition that has devastated her family, forcing her father to receive a heart transplant and killing six of her family members.
August 19, 2022
Drug offers more convenient approach for those with hereditary transthyretin amyloidosis